Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage 
Non-small Cell Lung Cancer by Anhui SHI, Guangying ZHU

Get full text

A Randomized Phase I/II Trial to Compare Weekly Usage with Triple Weekly Usage of Paclitaxel in Concurrent Radiochemotherapy for Patients with Locally Advanced Non-small Cell Lung... by Anhui SHI, Guangying ZHU, Rong YU, Yingjie WANG, Tingyi XIA

Get full text

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT by Junyue Shen, Dan Yang, Mailin Chen, Leilei Jiang, Xin Dong, Dongming Li, Rong Yu, Huiming Yu, Anhui Shi

Get full text

Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation 
with Concurrent Twice-daily Radiotherapy for Patients 
with Limited-stage Small Cell Lung Cancer by Jing YOU, Huiming YU, Maxiaowei SONG, Chen SHI, Xiaohang WANG, Ye ZHENG, Rong YU, Anhui SHI, Guangying ZHU

Get full text

A retrospective study of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in preventing neutropenia during definitive concurrent chemoradiotherapy in... by Xin Dong, Wei Deng, Leilei Jiang, Dan Yang, Huiming Yu, Dongming Li, Anhui Shi, Rong Yu, Weihu Wang

Get full text

Deficiencies in the Diagnosis and Treatment of Pulmonary Metastatic Osteosarcoma: 
A Chinese Multidisciplinary Survey by Xiaozheng KANG, Zhen HUANG, Anhui SHI, Jie WANG, Dongmei LIN, Yingshi SUN, Guangying ZHU, Xiaohui NIU, Keneng CHEN

Get full text

Role of EGFR Mutation Status in Patients with Stage III Non-squamous Non-small Cell Lung Cancer Treated with Chemoradiotherapy by Fuhai LI, Hua BAI, Xia’nan LI, Meina WU, Rong YU, Anhui SHI, Li YIN, Jie WANG, Guangying ZHU

Get full text

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer by Dan Yang, Jianing Cui, Jun Zhao, Jing You, Rong Yu, Huiming Yu, Leilei Jiang, Dongming Li, Bo Xu, Anhui Shi

Get full text

Cone‐beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients by Qingjin Qin, Anhui Shi, Ran Zhang, Qiang Wen, Tianye Niu, Jinhu Chen, Qingtao Qiu, Yidong Wan, Xiaorong Sun, Ligang Xing

Get full text

Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers by Xin Sui, Leilei Jiang, Huajing Teng, Lan Mi, Bo Li, Anhui Shi, Rong Yu, Dongming Li, Xin Dong, Dan Yang, Huiming Yu, Weihu Wang

Get full text

First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer by Lijuan Li, Dan Yang, Yanmei Min, Anyan Liao, Jing Zhao, Leilei Jiang, Xin Dong, Wei Deng, Huiming Yu, Rong Yu, Jun Zhao, Anhui Shi

Get full text

Optimal first‐line treatment for advanced thymic carcinoma by Xue Yang, Minglei Zhuo, Anhui Shi, Shengnan Yang, Ziping Wang, Meina Wu, Tongtong An, Yuyan Wang, Jianjie Li, Jia Zhong, Hanxiao Chen, Bo Jia, Zhi Dong, Jun Zhao

Get full text

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer by Hongmei Lin, Yuhchyau Chen, Anhui Shi, Kishan J Pandya, Rong Yu, Yannan Yuan, Jiancheng Li, Hang Li, Yingjie Wang, Tingyi Xia, Linchun Feng, Huimin Ma, Jianhao Geng, Guangying Zhu

Get full text

Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial by Nan Bi, Lipin Liu, Jun Liang, Shixiu Wu, Ming Chen, Changxing Lv, Lujun Zhao, Anhui Shi, Wei Jiang, Yaping Xu, Zongmei Zhou, Jingbo Wang, Wenqing Wang, Dongfu Chen, Zhouguang Hui, Jima Lv, Hongxing Zhang, Qinfu Feng, Zefen Xiao, Xin Wang, Tao Zhang, Weibo Yin, Junling Li, Jie He, Luhua Wang

Get full text